Matt Krisiloff combines experience as both a biotech founder who raised over $100M for his own company Conception and a venture investor at SciFounders, giving him credibility with founders on fundraising and company-building challenges. He advocates strongly for founder-led biotech companies where technical founders grow into business leaders rather than being replaced by professional managers, and provides unusually specific guidance on equity allocation for scientists in startups.

• Deep interest in genetics and advanced biotechnology, viewing tools like gene editing as potential life-savers for millions. He advocates for ambitious national initiatives to support this, such as the creation of a government-funded biobank to sequence the genomes of citizens for broader medical benefit.
• Strong stance on founder responsiveness and speed as a vital signal of competence. He frequently cites his time working with Sam Altman to illustrate this point, noting that rapid reply times are a key trait of successful operators and something he actively looks for in founders.
• Focus on demographic challenges, particularly the sharp decline in birth rates, which he views as a massive social issue comparable to or exceeding climate change in impact. He connects this to a broader interest in how policy and technology might support new family structures and parenting in the future.
• Critical view of the friction between academic institutions and private startups, specifically regarding university overhead costs. He uses examples from his own experience sponsoring research to argue that excessive fees disincentivize public-private collaboration and slow down scientific progress.
• Emphasis on clear communication and storytelling during the fundraising process to stand out in a stagnant biotech market. He advises founders to avoid looking like niche derivative companies by demonstrating a deep understanding of the competitive landscape and proving why their specific approach is unique.